SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)

Market Cap	4.28B
Revenue (ttm)	972.81M
Net Income (ttm)	147.57M
Shares Out	n/a
EPS (ttm)	0.98
PE Ratio	29.04
Forward PE	26.42
Dividend	0.16 (0.59%)
Ex-Dividend Date	Feb 5, 2025

Volume	100
Average Volume	33,771
Open	28.00
Previous Close	27.35
Day's Range	27.35 - 28.70
52-Week Range	18.50 - 36.88
Beta	n/a
RSI	54.17
Earnings Date	Aug 12, 2025

About FRA:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1SXP

Financial Performance

In 2024, FRA:1SXP's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.